Records 1 - 30
| NAT2 and CYP2E1 polymorphisms and antituberculosis drug-induced hepatotoxicity in Peruvian patients.
Molecular genetics & genomic medicine 2022 Jun e1987.
Jaramillo-Valverde Luis, Levano Kelly S, Tarazona David D, Capristano Silvia, Zegarra-Chapoñan Roberto, Sanchez Cesar, Yufra-Picardo Velia M, Tarazona-Santos Eduardo, Ugarte-Gil Cesar, Guio Heinn
| CYP2C8 and CYP2E1 genetic variants increase risk of tuberculosis in northwest Chinese Han population.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2021 Aug 95 105022.
Xing Shishi, Wang Yuhe, He Xue, Yang Wei, Hu Qunying, He Yongjun, Yuan Dongya, Jin Tian
| Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis.
International journal of environmental research and public health 2019 Dec 17 (1): .
Yu Ya-Yen, Tsao Shih-Ming, Yang Wen-Ta, Huang Wei-Chang, Lin Ching-Hsiung, Chen Wei-Wen, Yang Shun-Fa, Chiou Hui-Ling, Huang Yi-W
| Relationship of anti-tuberculosis drug-induced liver injury and genetic polymorphisms in CYP2E1 and GST.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2019 Nov .
Santos Eliana Abreu, Gonçalves JoséCarlos Saraiva, Fleury Marcos K, Kritski Afrânio L, Oliveira Martha M, Velasque Luciane S, E Silva JoséRoberto Lapa, Estrela Ritade C Ássia
| Association of genetic polymorphisms of CYP2E1, NAT2, GST and SLCO1B1 with the risk of anti-tuberculosis drug-induced liver injury: a systematic review and meta-analysis.
BMJ open 2019 Aug 9 (8): e027940.
Yang Seungwon, Hwang Se Jung, Park Jung Yun, Chung Eun Kyoung, Lee Jangik
| CYP genetic variants and toxicity related to anti-tubercular agents: a systematic review and meta-analysis.
Systematic reviews 2018 11 7 (1): 204.
Richardson Marty, Kirkham Jamie, Dwan Kerry, Sloan Derek J, Davies Geraint, Jorgensen Andrea
| Genetic Polymorphisms of SLCO1B1, CYP2E1 and UGT1A1 and Susceptibility to Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Chinese Population-Based Prospective Case-Control Study.
Clinical drug investigation 2017 Sep .
Sun Qin, Liu Hai-Peng, Zheng Rui-Juan, Wang Peng, Liu Zhi-Bin, Sha Wei, Xiao He-Pi
| Factors associated with anti-TB drug-induced hepatotoxicity and genetic polymorphisms in indigenous and non-indigenous populations in Brazil.
Tuberculosis (Edinburgh, Scotland) 2016 Dec 101 15-24.
Heinrich Melissa M, Zembrzuski Verônica M, Ota Marcos M, Sacchi Flavia P, Teixeira Raquel L F, Cabello Acero Pedro H, Cunha Geraldo Marcelo, Souza-Santos Reinaldo, Croda Julio, Basta Paulo
| CYP2E1 polymorphism, acetylator profiles and drug-induced liver injury incidence of Indonesian tuberculosis patients.
The Indian journal of tuberculosis 2016 Jul 63 (3): 139-143.
Perwitasari Dyah A, Irham Lalu M, Darmawan Endang, Mulyani Ully A, Atthobari
| Risk factors of isoniazid-induced hepatotoxicity in Tunisian tuberculosis patients.
The pharmacogenomics journal 2016 Apr .
Ben Fredj N, Gam R, Kerkni E, Chaabane A, Chadly Z, Boughattas N, Aouam
| Isoniazid-induced polyneuropathy in a tuberculosis patient - implication for individual risk stratification with genotyping?
Brain and behavior 2015 Aug 5 (8): e00326.
Stettner Mark, Steinberger Daniela, Hartmann Christian J, Pabst Tatjana, Konta Lidija, Hartung Hans Peter, Kieseier Bernd
| The association between CYP2E1 polymorphisms and hepatotoxicity due to anti-tuberculosis drugs: a meta-analysis.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2014 Jun 24 34-40.
Sheng Yun-Jian, Wu Gang, He Hong-Yan, Chen Wen, Zou Yong-Sheng, Li Qin, Zhong Li, Huang Yong-Mao, Deng Cun-Lia
| Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity.
Tuberculosis (Edinburgh, Scotland) 2014 May 94 (3): 293-8.
Singla Neha, Gupta Dheeraj, Birbian Niti, Singh Jagt
| Genetic polymorphisms of CYP2E1 and GSTM1 loci and susceptibility to anti-tuberculosis drug-induced hepatotoxicity.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2014 May 18 (5): 588-93.
Sharma S K, Jha B K, Sharma A, Sreenivas V, Upadhyay V, Jaisinghani C, Singla R, Mishra H K, Soneja
| The role of cigarette smoking and liver enzymes polymorphisms in anti-tuberculosis drug-induced hepatotoxicity in Brazilian patients.
Tuberculosis (Edinburgh, Scotland) 2014 May 94 (3): 299-305.
Zaverucha-do-Valle Camila, Monteiro Sérgio P, El-Jaick Kênia B, Rosadas Leonardo A, Costa Marli J M, Quintana Marcel S B, de Castro Lia
| Association of genetic variants with anti-tuberculosis drug induced hepatotoxicity: a high resolution melting analysis.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2014 Apr 23 42-8.
Singh Meenakshi, Gupta Vinod H, Amarapurkar Deepak N, Joshi Jyotsna M, Baijal Rajiv, Ramegowda Praveenkumar H, Amarapurkar Anjali D, Wangikar Pramod
| N-acetyltransferase 2, cytochrome P4502E1 and glutathione S-transferase genotypes in antitubercular treatment-induced hepatotoxicity in North Indians.
Journal of clinical pharmacy and therapeutics 2014 Feb 39 (1): 91-6.
Rana S V, Sharma S K, Ola R P, Kamboj J K, Malik A, Morya R K, Sinha S
| Distribution of allelic and genotypic frequencies of NAT2 and CYP2E1 variants in Moroccan population.
BMC genetics 2014 15 (1): 156.
Guaoua Soukaina, Ratbi Ilham, Laarabi Fatima Zahra, Elalaoui Siham Chafai, Jaouad Imane Cherkaoui, Barkat Amina, Sefiani Abdelaz
| Genetic polymorphisms in metabolic enzymes and susceptibility to anti-tuberculosis drug-induced hepatic injury.
Genetics and molecular research : GMR 2014 13 (4): 9463-71.
Feng F M, Guo M, Chen Y, Li S M, Zhang P, Sun S F, Zhang G
| The incidence of liver injury in Uyghur patients treated for TB in Xinjiang Uyghur autonomous region, China, and its association with hepatic enzyme polymorphisms nat2, cyp2e1, gstm1 and gstt1.
PloS one 2014 9 (1): e85905.
Xiang Yang, Ma Long, Wu Weidong, Liu Wei, Li Yongguang, Zhu Xia, Wang Qian, Ma Jinfeng, Cao Mingqin, Wang Qian, Yao Xuemei, Yang Lei, Wubuli Atikaimu, Merle Corinne, Milligan Paul, Mao Ying, Gu Jiayi, Xin Xium
| Association of N-acetyltransferase 2 and cytochrome P450 2E1 gene polymorphisms with antituberculosis drug-induced hepatotoxicity in Western India.
Journal of gastroenterology and hepatology 2013 Aug 28 (8): 1368-74.
Gupta Vinod H, Amarapurkar Deepak N, Singh Meenakshi, Sasi Preetha, Joshi Jyotsna M, Baijal Rajiv, Ramegowda Praveenkumar H, Amarapurkar Anjali D, Joshi Kalpana, Wangikar Pramod
| N-acetyl transferase 2 and cytochrome P450 2E1 genes and isoniazid-induced hepatotoxicity in Brazilian patients.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2013 Jan .
Santos NP, Callegari-Jacques SM, Santos AK, Silva CA, Vallinoto AC, Fernandes DC, de Carvalho DC, Santos SE, Hutz MH
| Relationship of NAT2, CYP2E1 and GSTM1/GSTT1 polymorphisms with mild elevation of liver enzymes in Brazilian individuals under anti-tuberculosis drug therapy.
Clinica chimica acta; international journal of clinical chemistry 2013 Jan 415 215-9.
Forestiero Francisco Jose, Cecon Leticia, Hirata Mario Hirouki, de Melo Fernando Fiuza, Cardoso Rosilene Fressatti, Cerda Alvaro, Hirata Rosario Dominguez Cres
| Cytochrome P450 2E1 gene polymorphisms/haplotypes and anti-tuberculosis drug-induced hepatitis in a Chinese cohort.
PloS one 2013 8 (2): e57526.
Tang Shaowen, Lv Xiaozhen, Zhang Yuan, Wu Shanshan, Yang Zhirong, Xia Yinyin, Tu Dehua, Deng Peiyuan, Ma Yu, Chen Dafang, Zhan Siy
| CYP2E1 RsaI/PstI polymorphism and risk of anti-tuberculosis drug-induced liver injury: a meta-analysis.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2012 Dec 16 (12): 1574-81.
Deng R, Yang T, Wang Y, Tang
| Genetic interaction between NAT2, GSTM1, GSTT1, CYP2E1, and environmental factors is associated with adverse reactions to anti-tuberculosis drugs.
Molecular diagnosis & therapy 2012 Jul .
Costa GN, Magno LA, Santana CV, Konstantinovas C, Saito ST, Machado M, Di Pietro G, Bastos-Rodrigues L, Miranda DM, De Marco LA, Romano-Silva MA, Rios-Santos F
| NAT2 and CYP2E1 polymorphisms associated with antituberculosis drug-induced hepatotoxicity in Chinese patients.
Clinical and experimental pharmacology & physiology 2012 Jun 39 (6): 535-43.
An Hui-Ru, Wu Xue-Qiong, Wang Zhong-Yuan, Zhang Jun-Xian, Liang Y
| Functional polymorphisms in CYP2C19 & CYP3A5 genes associated with decreased susceptibility for paediatric tuberculosis.
The Indian journal of medical research 2012 May 135 (5): 642-9.
Feng Wei-Xing, Liu Fang, Gu Yi, Jiao Wei-Wei, Sun Lin, Xiao Jing, Wu Xi-Rong, Miao Qing, Shen Chen, Shen Dan, Shen Ado
| N-acetyltransferase and cytochrome P450 2E1 gene polymorphisms and susceptibility to antituberculosis drug hepatotoxicity in an Indian population.
The National medical journal of India 0 26 (5): 260-5.
Mishra Swapnil, Daschakraborty Sunilbaran, Shukla Pallavi, Kapoor Prerna, Aggarwal Rake
| Polymorphisms of NAT2, CYP2E1, GST, and HLA related to drug-induced liver injury in indonesian tuberculosis patients.
International journal of mycobacteriology 0 7 (4): 380-386.
Perwitasari Dyah Aryani, Darmawan Endang, Mulyani Ully Adhi, Vlies Pieter Van Der, Alffenaar Jan-Willem C, Atthobar Jarir, Wilffert B